Author:
Langeberg Wendy J.,Siozon Conchitina C.,Page John H.,Morrow P. K.,Chia Victoria M.
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. National Comprehensive Cancer Network (2013) NCCN clinical practice guidelines in oncology. Myeloid growth factors. V.2.2013 ( www.nccn.org/professionals/physician_gls/PDF/myeloid_growth.pdf )
2. Lyman GH, Michels SL, Reynolds MW et al (2010) Risk of mortality in patients with cancer who experience febrile neutropenia. Cancer 116:5555–5563
3. Crawford J, Dale DC, Kuderer NM et al (2008) Risk and timing of neutropenia events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice. J Natl Compr Cancer Netw 6:109–118
4. Kuderer NM, Dale DC, Crawford J et al (2006) Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 106:2258–2266
5. Kuderer NM, Dale DC, Crawford J, Lyman GH (2007) Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review. J Clin Oncol 25:3158
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献